xuMkj6

OPCIONES ANTICONCEPTIVAS PARA PERSONAS CON VIH
priate contraception for HIV-1 infected women?”, en Br J Obstet Gynaecol,
2001;108(8):784-790.
(28) Sinei, S. y Morrison, C.: “Complications of use of intrauterine devices
among HIV-1 infected women”, en Lancet, 1998;351:38-1241.
(29) European Study Group on Heterosexual Transmission of HIV-1:
“Comparison of female to male and male to female transmission of HIV-1
in 563 stable couples”, en BMJ, 1992;304:809-813.
(30) Richardson, B. y Morrison C,: “Effect of intrauterine device use on cervical
shedding of HIV-1 DNA”, en AIDS, 1999;13:2091-2097.
(31) Mostad, S.; Overbaugh, J. et al.: “Hormonal contraception, vitamin A deficiency,
and other risk factors for shedding of HIV-1 infected cells from the
cervix and vagina”, en Lancet, 1997;350:922-927.
(32) Cooling, H.: “Successful use of levonorgestrel intrauterine system in a HIV
positive woman”, en Br J Fam Plann, 1999;25:25-26.
(33) Castaño, P. M.: “Use of intrauterine devices and systems by HIV-infected
women”, en Contraception, 2007;75 S51-S57.
(34) Heikinheimo, O.; Lehtovirta, P.; Suni, J. y Paavonen, J.: “The levonorgestrelreleasing
intrauterine system (LNG-IUS) in HIV-infected women-effects on
bleeding patterns, ovarian function and genital shedding of HIV”, en Hum
Reprod, 2006;21:2857-61.
(35) Richardson, B. A., Morrison, C. S.; Sekadde-Kigonduy C. et al.: “Effect of
intrauterine device use on cervical shedding of HIV-1 DNA”, en AIDS,
1999;13:2091-7.
(36) Lehtovirta, P.; Paavonen, J. y Heikinheimo, O.: “Experience with the levonorgestrel-releasing
intrauterine system among HIV-infected women”, en
Contraception, 2007;75:37-41.
(37) Berer, M.: “Report of an International Conference. Microbicides 2000”, en
Reproductive Health Matters, 2000;8(15).
(38) Malkovsky, M.; Newell, A. y Dalgleish, A.: “Inactivation of HIV by nonoxinol-9”,
en Lancet, 1988;1:645.
(39) Jennings, R. y Clegg, A.: “The inhibitory effect of spermicidal agents on
replication of HSV-2 and HIV-1 in vitro”, en J Antimicrob Chemother,
1993;32:71-82.
(40) Niruthisard, S.; Roddy, R. y Chutivongse, S.: “The effects of frequent
nonoxynol-9 use on the vaginal and cervical mucosa”, en Sex Transm Dis,
1991;18:176-179.
(41) Roddy, R.; Cordero, M.; Cordero, C. y Fortney, J.: “A dosing study of nono-
63